Company Filing History:
Years Active: 2017-2025
Title: Alfonso Chavez: Innovator in Lead Fixation Devices
Introduction
Alfonso Chavez, an accomplished inventor based in San Jose, CA, has significantly contributed to the medical device industry with his innovative designs. With a total of six patents to his name, Chavez is known for his pioneering work in lead fixation devices that enhance the secure attachment of leads to the cranium.
Latest Patents
Chavez's most recent inventions include two notable patents focused on lead fixation devices. The first involves a mechanism specifically designed to secure a lead relative to a hole formed through the skull. This device features a skull attachment member that incorporates a lead compression mechanism, allowing the diameter of the passageway to transition effectively during the insertion and removal of an implant tool.
The second patent details hinged lead fixation devices that provide a versatile approach to securing leads against the skull's surface. This invention includes a locking member that rotates relative to the skull attachment member, transitioning the device between a closed state and an open state, thereby facilitating easier lead placement and securing.
Career Highlights
Alfonso Chavez is currently employed at Neuropace, Inc., a company specializing in advanced neuromodulation therapies. His role at Neuropace, along with his patent acquisitions, showcases his commitment to innovation in medical technology, particularly in the field of neurology.
Collaborations
In his career, Chavez has collaborated with notable colleagues such as Peter B. Weber and Paul M. Paspa. Working alongside these professionals, he has made significant strides in designing products that improve patient outcomes through secure medical device functionality.
Conclusion
Alfonso Chavez stands out as a key figure in the field of medical innovations, particularly through his creative developments in lead fixation devices. His patents not only reflect his expertise and dedication but also reinforce the ongoing advancements in technologies that support neurological health.